Marva Moxey-Mims, M.D., came to Children’s National Health System from the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health in Bethesda, Maryland. There she served as deputy director for clinical science in the Division of Kidney, Urologic and Hematologic Diseases, overseeing a portfolio of research including trials for kidney disease and genitourinary dysfunction in adults and children, and director of the pediatric nephrology program. In addition she managed the division’s small business grants for kidney research.
Two of the studies that Dr. Moxey-Mims initiated, and of which she is most proud, are the ongoing Chronic Kidney Disease in Children (CKiD) study and the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) trial. CKiD is the largest study of pediatric chronic kidney disease ever conducted in North America, and it is yielding a lot of information that will lead to better understanding and treatment of chronic kidney disease in children. RIVUR was a large trial undertaken to understand the effectiveness of prophylactic antimicrobial treatment in children with vesicoureteral reflux and the primary trial results were published in the New England Journal of Medicine.
Dr. Moxey-Mims’ focus at Children’s National will be on clinical research to improve the care of children with kidney disease, and as a tool to educate trainees. She received an undergraduate degree from McGill University in Montreal, Canada, and a medical degree from Howard University in Washington, D.C. She completed a pediatric residency and clinical pediatric nephrology training at Children’s National, followed by a research fellowship at the National Institute of Allergy and Infectious Diseases at the NIH. She is board-certified in pediatrics and pediatric nephrology. Dr. Moxey-Mims is a member of several national committees and has more than 90 scientific publications, including peer-reviewed articles and book chapters.